Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Viral infections and sphingolipids.

Schneider-Schaulies J, Schneider-Schaulies S.

Handb Exp Pharmacol. 2013;(216):321-40. doi: 10.1007/978-3-7091-1511-4_16. Review.

PMID:
23563664
2.

Inhibitors of virus replication: recent developments and prospects.

Magden J, Kääriäinen L, Ahola T.

Appl Microbiol Biotechnol. 2005 Mar;66(6):612-21. Epub 2004 Dec 9. Review.

PMID:
15592828
3.

[Peptides--a new strategy for combating viral infections].

Kołodziej M, Joniec J, Bartoszcze M, Mirski T, Gryko R.

Przegl Epidemiol. 2011;65(3):477-82. Review. Polish.

PMID:
22184952
4.

Antiviral properties of lactoferrin--a natural immunity molecule.

Berlutti F, Pantanella F, Natalizi T, Frioni A, Paesano R, Polimeni A, Valenti P.

Molecules. 2011 Aug 16;16(8):6992-7018. doi: 10.3390/molecules16086992. Review.

5.

Sphingolipids in viral infection.

Schneider-Schaulies J, Schneider-Schaulies S.

Biol Chem. 2015 Jun;396(6-7):585-95. doi: 10.1515/hsz-2014-0273.

PMID:
25525752
6.

Cell cycle regulation during viral infection.

Bagga S, Bouchard MJ.

Methods Mol Biol. 2014;1170:165-227. doi: 10.1007/978-1-4939-0888-2_10. Review.

PMID:
24906315
7.

Signalling in viral entry.

Greber UF.

Cell Mol Life Sci. 2002 Apr;59(4):608-26. Review.

PMID:
12022470
8.

Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review).

Rawat SS, Viard M, Gallo SA, Rein A, Blumenthal R, Puri A.

Mol Membr Biol. 2003 Jul-Sep;20(3):243-54. Review.

PMID:
12893532
9.

MAVS: a new weapon in the fight against viral infections.

Boga JA, de Oña M, Melon S, Alvarez-Arguelles ME, Morilla A, Coto-Montes A.

Recent Pat Endocr Metab Immune Drug Discov. 2013 May;7(2):115-9. Review.

PMID:
23432157
10.

Intracellular redox signaling as therapeutic target for novel antiviral strategy.

Nencioni L, Sgarbanti R, Amatore D, Checconi P, Celestino I, Limongi D, Anticoli S, Palamara AT, Garaci E.

Curr Pharm Des. 2011 Dec;17(35):3898-904. Review.

PMID:
21933147
11.

Defensins in viral infections.

Ding J, Chou YY, Chang TL.

J Innate Immun. 2009;1(5):413-20. doi: 10.1159/000226256. Epub 2009 Jun 24. Review.

12.

Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection.

Lee SM, Yen HL.

Antiviral Res. 2012 Dec;96(3):391-404. doi: 10.1016/j.antiviral.2012.09.013. Epub 2012 Sep 26. Review.

PMID:
23022351
13.

Multifaceted roles for lipids in viral infection.

Heaton NS, Randall G.

Trends Microbiol. 2011 Jul;19(7):368-75. doi: 10.1016/j.tim.2011.03.007. Epub 2011 Apr 29. Review.

14.

Virus-host interactomes--antiviral drug discovery.

Ma-Lauer Y, Lei J, Hilgenfeld R, von Brunn A.

Curr Opin Virol. 2012 Oct;2(5):614-21. doi: 10.1016/j.coviro.2012.09.003. Review.

PMID:
23057872
15.

Manipulation of dendritic cell function by viruses.

Cunningham AL, Donaghy H, Harman AN, Kim M, Turville SG.

Curr Opin Microbiol. 2010 Aug;13(4):524-9. doi: 10.1016/j.mib.2010.06.002. Epub 2010 Jul 2. Review.

PMID:
20598938
16.

Antiviral strategies.

Müller B, Kräusslich HG.

Handb Exp Pharmacol. 2009;(189):1-24. doi: 10.1007/978-3-540-79086-0_1. Review.

PMID:
19048195
17.

Current progress in antiviral strategies.

Lou Z, Sun Y, Rao Z.

Trends Pharmacol Sci. 2014 Feb;35(2):86-102. doi: 10.1016/j.tips.2013.11.006. Epub 2014 Jan 14. Review.

PMID:
24439476
18.

New horizons for antiviral drug discovery from virus-host protein interaction networks.

de Chassey B, Meyniel-Schicklin L, Aublin-Gex A, André P, Lotteau V.

Curr Opin Virol. 2012 Oct;2(5):606-13. doi: 10.1016/j.coviro.2012.09.001. Epub 2012 Sep 29. Review.

PMID:
23025912
19.

War and peace between microbes: HIV-1 interactions with coinfecting viruses.

Lisco A, Vanpouille C, Margolis L.

Cell Host Microbe. 2009 Nov 19;6(5):403-8. doi: 10.1016/j.chom.2009.10.010. Review.

20.

Molecular pathways in virus-induced cytokine production.

Mogensen TH, Paludan SR.

Microbiol Mol Biol Rev. 2001 Mar;65(1):131-50. Review.

Supplemental Content

Support Center